Clonazepam

Quick links to important sections

Clonazepam

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clonazepam

Quick Facts

Property Description
Active ingredient Clonazepam (C15H10ClN3O3)
Form Oral Tablets, Orally Disintegrating Tablets (ODTs), Oral Solution
Pharmacological class Benzodiazepine; Central Nervous System (CNS) Depressant
General purpose To stabilize neural activity and reduce hyperexcitability
Origin Synthetic (Chemically synthesized)

What Type of Medicine is Clonazepam?

Clonazepam is a potent, synthetic pharmaceutical compound primarily classified as a Benzodiazepine and a Central Nervous System (CNS) Depressant. The drug entity contains only one active ingredient, which is Clonazepam itself. This classification confirms it acts by enhancing the brain's natural inhibitory systems, an effect recognized for its therapeutic potential in controlling neural overactivity. Unlike remedies derived from natural sources, Clonazepam is entirely manufactured through chemical synthesis, defining its origin/type as fully synthetic.


Forms and General Purpose of Clonazepam

The medication is most commonly administered by the oral route of administration, available as standard oral tablets and as a liquid oral solution. A differentiating factor is its availability as an Orally Disintegrating Tablet (ODT), a unique form noted for facilitating administration to patients who may have difficulty swallowing solid medication. As a high-potency, long-acting benzodiazepine, the general therapeutic goal of Clonazepam is to achieve neurological stability and tranquility by reducing excessive, uncontrolled electrical activity in the brain. This CNS depressant is utilized for its core utility in managing conditions rooted in persistent neuronal hyperexcitability, such as providing consistent stabilization for individuals experiencing generalized anxiety or recurrent seizure disorders.


Clonazepam as a Single-Ingredient Agent

Clonazepam is exclusively formulated as a single-ingredient product, containing only the active pharmaceutical ingredient plus various inactive excipients, carriers, and binders. Its status as a single agent ensures all therapeutic effects are derived solely from the compound’s distinct mechanism as a GABA-A receptor modulator, without relying on synergistic or additive effects from other drug classes. This simplicity in composition underscores its focused pharmacological action.

Regulatory References

  1. Clonazepam: MedlinePlus Drug Information
  2. Clonazepam - StatPearls - NCBI Bookshelf

What side effects are possible with Clonazepam?

Possible Side Effects and Safety Information

The safety profile of Clonazepam, a central nervous system (CNS) depressant, is categorized based on adverse reactions observed in clinical use and documented in regulatory labeling. The most frequently observed effects are related to its CNS depressant action, which are typically more pronounced at the start of therapy and may lessen with continued use.

Frequency-Classified Adverse Reactions

The most common adverse reactions, as classified in official documents, primarily affect the nervous system and motor function:

Classification Examples of Adverse Reactions (by SOC)
Very Common Somnolence (Drowsiness/Sleepiness), Fatigue
Common Ataxia (lack of coordination), Dizziness, Muscle weakness, Depression, Memory disturbance

Serious Adverse Reactions and Safety Constraints

Official prescribing information highlights several serious safety considerations. Clonazepam carries a risk of physical and psychological dependence, and this risk increases with the duration of treatment and higher doses. Abrupt discontinuation can lead to severe withdrawal reactions, including seizures.

Due to its CNS depressant properties, concomitant use with opioids or alcohol significantly increases the risk of severe respiratory depression, coma, and death. Furthermore, like other antiepileptic drugs (AEDs), Clonazepam is associated with an increased risk of suicidal behavior and ideation.

Population and Use Restrictions

Clonazepam is contraindicated in patients with clinical evidence of severe hepatic impairment due to its metabolism in the liver. Older adults may experience increased sensitivity to the CNS depressant effects, leading to a heightened risk of confusion and falls. The drug's effects can impair the ability to perform tasks requiring mental alertness, such as driving or operating machinery.

Overdose and Emergency Response

Overdose and When to Seek Help

The official documentation for Clonazepam overdose focuses on severe manifestations of Central Nervous System (CNS) depression and mandated emergency actions. An overdose primarily presents with CNS depression, with documented clinical manifestations ranging from profound drowsiness and confusion to impaired coordination (ataxia), slurred speech (dysarthria), and impaired reflexes. Severe exposure can rapidly lead to life-threatening complications involving the respiratory and cardiovascular systems.

The most serious outcomes listed in regulatory documents are respiratory depression, apnea (cessation of breathing), hypotension, and coma, carrying an elevated risk of cardiac arrest and death. This risk is dramatically increased when Clonazepam is ingested concurrently with other CNS depressants, particularly alcohol or opioids. Special observation is required for elderly patients, in whom overdose-induced coma may be more protracted.

Regulatory labeling mandates that individuals seek immediate medical attention and contact emergency services (e.g., 911 or Poison Help Line) upon any suspicion of an overdose. The core management strategy involves symptomatic and supportive treatment, with a critical focus on maintaining a clear airway and ensuring adequate ventilation. While the benzodiazepine antagonist Flumazenil may be considered, official guidance contains a strong warning that it is not indicated in epileptic patients treated with the medication due to the potential to precipitate dangerous, life-threatening seizures.

Therapeutic Uses of Clonazepam

The medication is commonly used across conditions presenting with acute or disruptive symptom patterns related to heightened physiological activity. This includes applications for conditions characterized by specific seizure disorders, such as Lennox-Gastaut, myoclonic, akinetic, and absence seizures, as well as panic disorder and pronounced symptoms associated with severe generalized anxiety. It is applied in situations involving symptomatic discomfort to address symptoms of increased neurological or muscular activity. This supportive therapeutic benefit helps address symptom clusters that may become intense, which contributes to easing the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable.

Quick Fact: Relief for Heightened Symptoms

Area of Benefit Symptom Category Addressed
Neurological Stability Symptoms of increased neurological activity (symptoms that interfere with daily functioning)
Anxiolytic Support Symptoms related to acute fear and intense emotional distress (panic attacks)
Motor Symptom Relief Symptoms of increased muscular activity (involuntary motor disturbances or spasms)

Eligibility and Restrictions for Use

Regulatory documents define specific populations for whom the use of clonazepam is either contraindicated or requires special caution.

Official Exclusion Criteria (Contraindications)

Clonazepam is officially contraindicated in patients with the following conditions:

  • A known history of hypersensitivity or allergic reaction to clonazepam or any other benzodiazepine.
  • Significant liver disease (clinical or biochemical evidence of severe hepatic impairment), due to the drug's metabolism in the liver.
  • Acute narrow-angle glaucoma. (Note: It may be used in patients with open-angle glaucoma who are receiving appropriate treatment.)

Eligibility Restrictions and Special Populations

Population Group Eligibility Status (Regulatory Note)
Pediatric Patients (<18 years) Not approved for the treatment of panic disorder; approved for seizure disorders.
Elderly Patients (≥65 years) Caution advised; treatment should be initiated at a low dose due to increased risk of side effects like confusion and sedation.
Pregnant or Planning Pregnancy Former FDA Category D. Should be used only if the benefit outweighs the risk. Prolonged use late in pregnancy may cause withdrawal symptoms in the newborn.
Breastfeeding Excreted into human milk. A decision must be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Conditions for Caution Chronic pulmonary insufficiency (risk of respiratory depression), renal or moderate hepatic impairment, and a history of alcohol or drug abuse require careful monitoring.

What should I know about interactions with other medicines?

The official interaction profile for Clonazepam is governed by two main patterns: additive Central Nervous System (CNS)-depressant effects and pharmacokinetic changes via hepatic metabolism.

Formal Regulatory Warnings

A Boxed Warning is issued for the concomitant use of Clonazepam and Opioids, as this combination may result in profound sedation, respiratory depression, coma, and death. Similarly, co-administration with alcohol (ethanol) or other CNS-depressant medicinal products is warned against due to the resultant interference with cognitive and motor performance. The presence of significant liver disease is a formal contraindication because the liver's role in the drug's metabolism means impairment may severely compromise drug elimination, leading to accumulation.

Metabolic (Pharmacokinetic) Interactions

Clonazepam is metabolized by the Cytochrome P-450 3A (CYP3A) enzyme system. Co-administration with CYP3A4 inducers, such as Carbamazepine or Phenytoin, may accelerate metabolism, causing a decrease in plasma Clonazepam levels. Conversely, CYP3A4 inhibitors can impair metabolism, potentially leading to exaggerated concentrations and effects. These enzyme-mediated interactions may necessitate closer monitoring when co-administering drugs that affect this metabolic pathway.

Population-Specific Cautions

Elderly or debilitated patients are noted to be more susceptible to the CNS depressant effects of the drug and associated interactions.

Mechanism of Action

How Clonazepam Works

Clonazepam, a benzodiazepine, acts primarily within the central nervous system (CNS) by enhancing the function of the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA). This action modulates neuronal excitability within the CNS.

Clonazepam functions as a positive allosteric modulator at the GABA-A receptor. This binding occurs at a site distinct from where GABA binds, and it increases the frequency of the receptor's chloride channel opening in the presence of GABA. This core molecular interaction is crucial for initiating the drug's downstream effects.

The increased opening frequency of the associated chloride ion channel leads to a greater influx of negatively charged chloride ions ( Cl^-) into the postsynaptic neuron. This Cl^- influx hyperpolarizes the neuron's cell membrane, making it significantly less susceptible to excitation. The resulting physiological effect is the attenuation of rapid, high-frequency neuronal depolarization in targeted circuits, thereby dampening the overall hyperexcitability of specific neural pathways.

Dosage and Administration Information

The administration of clonazepam is structured around a protocol governing route, dosage, and frequency. The primary method of administration is oral, available as tablets, an oral solution, and orally disintegrating tablets (ODTs). A solution for injection is also available for intravenous (IV) administration, typically reserved for acute, supervised clinical settings. Oral forms may be taken with or without food.

Dosing follows a titration schedule, initiating at a low daily amount which is then slowly increased in small increments (e.g., every three days) to reach a maintenance level. For most adult uses, the total dose is administered in divided doses throughout the day. If the dosage cannot be evenly split, the largest portion is typically administered at bedtime to minimize daytime effects.

Specific instructions apply to particular formulations: ODTs are handled with dry hands to avoid premature dissolution, and the liquid solution requires measurement using a calibrated dropper or syringe for accuracy. For older adults, administration begins at a lower initial dose, such as 0.25 mg twice daily for panic disorder, due to population-specific adjustments. The treatment protocol also dictates that discontinuation involves a gradual, stepwise dose reduction rather than abrupt cessation.

Recent Clinical Evidence

Clonazepam: Recent Clinical Evidence

Clonazepam is a long-acting benzodiazepine primarily approved for the treatment of seizure disorders and panic disorder. Clinical research focuses on its use in these approved indications, its effectiveness in specific patient populations, and its application in other related conditions.


Clinical Trials in Panic Disorder

Double-blind, placebo-controlled studies have evaluated the compound's effect in adult patients diagnosed with panic disorder, with or without agoraphobia. These trials reported that the proportion of patients who were panic-attack-free at the study endpoint was significantly higher in the clonazepam group compared to the placebo group. The minimum effective dosage for panic attacks in some fixed-dose studies was found to be 1 mg/day.

Research has also explored augmentation strategies, noting that the combined use of clonazepam with a selective serotonin reuptake inhibitor (SSRI) may be associated with an accelerated reduction in panic disorder symptoms.


Evidence in Seizure Disorders

Clonazepam is indicated for certain seizure types, including Lennox-Gastaut syndrome, akinetic, and myoclonic seizures. Studies show it is capable of suppressing the characteristic spike and wave discharge associated with absence seizures (petit mal). However, evidence from randomized controlled trials comparing clonazepam monotherapy to other anti-epileptic drugs for newly diagnosed epilepsy remains limited, particularly regarding long-term efficacy and tolerability.

Focus Area Key Research Findings
Pediatric Epilepsy Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit its usefulness in children with seizure disorders.
Antimanic Efficacy Systematic reviews of randomized controlled trials suggest the compound may be no different to lithium and haloperidol in terms of efficacy for acute mania, an off-label use.

Key Studies & References

  1. Clonazepam for acute mania: a systematic review and meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Clonazepam (FAQ)


Q: How quickly does Clonazepam usually start working after you take it?

Clonazepam is generally a long-acting medicine. According to official drug information, for conditions like panic disorder and restless legs syndrome, the medicine typically begins to produce effects in about one hour after it is taken. The full therapeutic effect for seizure or muscle spasms may take longer.


Q: Does Clonazepam stay in your system for a long time?

Yes, it is classified as a long-acting benzodiazepine. The time it takes for half of the drug to be eliminated from the body, known as its elimination half-life, is generally reported to be between 19 and 60 hours. This long half-life supports its classification as a long-acting benzodiazepine.


Q: What are the general rules regarding driving or operating machinery while taking Clonazepam?

Due to its function as a central nervous system depressant, Clonazepam can impair coordination, motor skills, and mental alertness. Official labeling advises patients not to drive or operate heavy machinery until they know precisely how the medicine affects their physical and mental performance.


Q: Is it true that Clonazepam can cause problems with memory?

Yes, official documents list memory disturbance or problems with memory as a common adverse reaction related to the nervous system and cognitive function. This is a documented effect associated with the benzodiazepine class.


Q: Are there any common side effects people notice when first starting Clonazepam?

Official information indicates that adverse effects, particularly those related to the central nervous system (such as somnolence or fatigue), are often more noticeable at the start of therapy. These effects are typically more noticeable initially and may decrease with continued use, but individual experience can vary.


Q: Is it normal to feel a bit sleepy or 'out of it' when you first start taking Clonazepam?

Official documents classify somnolence (sleepiness) and fatigue as very common adverse reactions. These effects are typically more pronounced during the beginning of treatment as your body adjusts to the drug.


Q: What are the most common reasons why a doctor might decide to stop a patient's Clonazepam prescription?

A doctor may decide to discontinue the medicine if a patient develops serious adverse reactions, shows signs of physical dependence, or develops a contraindication like severe liver disease. The treatment protocol dictates that discontinuation should involve a gradual dose reduction.


Q: Can Clonazepam be crushed or chewed, or should it always be swallowed whole?

Standard oral tablets are formulated to be swallowed whole, according to administration guidelines. Special formulations, like the Orally Disintegrating Tablet (ODT) and the oral solution, are specifically designed for those who may have difficulty swallowing solid tablets.


Q: How is the feeling of 'rebound anxiety' described when reducing Clonazepam?

Official regulatory documents use the term withdrawal reactions to describe the experience of symptoms like anxiety, restlessness, or insomnia returning or worsening. This can occur following abrupt dose reduction or cessation, emphasizing the need for a gradual reduction protocol.


Q: What types of food or drinks should be avoided while taking Clonazepam?

Official labeling contains a Boxed Warning against the concomitant use of alcohol due to the serious risk of increased sedation, respiratory depression, coma, and death. However, there are no known restrictions regarding nonalcoholic foods or drinks listed in the official patient information.


Q: Does Clonazepam affect a person's appetite or cause weight changes?

Official documentation notes that decreased appetite is a reported adverse reaction. Other changes, such as increased appetite, weight gain, or weight loss, have also been noted in case reports as a possible effect on the metabolism.


Q: What is the expected time frame for noticing the full benefit of Clonazepam?

The dosage is typically adjusted gradually over time, following a specific titration schedule. For seizure disorders and muscle spasms, official information indicates it may take up to a week of treatment to notice the full therapeutic benefit.


Q: Can Clonazepam be detected in standard drug tests?

Clonazepam is classified as a federally controlled substance (Schedule IV) and can be detected in drug tests. Tests often look for the drug itself and its major metabolite, 7-aminoclonazepam.


Q: Is Clonazepam considered a narcotic or an opiate?

No. Clonazepam is a member of the benzodiazepine drug class, which acts on the central nervous system. It is classified as a Schedule IV controlled substance but is not considered a narcotic or an opiate.


Q: Why is Clonazepam sometimes compared to other benzodiazepines like Xanax (alprazolam)?

Clonazepam is often discussed alongside other medicines in the same benzodiazepine class because they all share a common mechanism of action by enhancing the effects of the neurotransmitter GABA. This shared classification is the basis for high-level comparisons in discussions of therapeutic options.


Q: What are the main differences between Clonazepam and lorazepam (Ativan)?

Both medicines belong to the benzodiazepine class. Differences between them are primarily in their pharmacokinetic properties, such as their half-life, which influences the duration of effect and how they are used clinically for different conditions.


Q: Does Clonazepam affect sleep even if it's taken during the day?

As a Central Nervous System (CNS) depressant, one of the most common adverse reactions is somnolence (sleepiness). This effect may be noticeable even when the medicine is taken earlier in the day.


Q: Can Clonazepam be taken long-term for chronic conditions?

While approved for chronic conditions like certain seizure disorders, official prescribing information notes that the risk of physical and psychological dependence increases with the duration of treatment and with higher doses.


Q: What happens if you miss a dose of Clonazepam?

The standard protocol for a missed dose, as described in official patient information, is to take the dose as soon as it is remembered unless it is almost time for the next scheduled dose. If so, the missed dose is skipped entirely, and the next dose is taken at the usual time. Two doses should never be taken at the same time.


Q: What common supplements or vitamins might interact with Clonazepam?

Clonazepam interacts with medicines that affect the CYP3A4 enzyme system in the liver. Regulatory documents require full disclosure of all prescription, over-the-counter, and herbal products or supplements being taken due to the potential for interactions.


Q: Do doctors ever prescribe Clonazepam for nerve pain or muscle spasms?

Clonazepam is indicated for the treatment of certain seizure disorders, panic disorder, and conditions characterized by involuntary muscle spasms.


Q: Why is Clonazepam sometimes referred to by its brand name, Klonopin?

Clonazepam is the generic name for the active drug ingredient. The common brand name by which it is often known is Klonopin, which was used when the medicine was first introduced to the market.


Q: Can Clonazepam be used to treat panic attacks as they are happening?

The medicine is officially approved for the treatment of panic disorder. Based on its pharmacokinetic properties, including a time of onset that typically begins in about one hour, it is used for maintenance treatment of the disorder.


Q: Does taking Clonazepam require any special monitoring or blood tests?

The drug’s labeling requires regular patient monitoring, which may involve blood tests (such as liver function tests) to check for potential changes in the blood or liver function, especially during long-term use.


Q: What research is currently being explored for new uses of Clonazepam?

Current clinical research is investigating the use of the medicine for conditions such as Burning Mouth Syndrome and exploring whether low doses might affect cognitive function in certain patient populations, according to clinical trials registries.


Q: What are some non-habit-forming alternatives to Clonazepam that people often ask about?

Non-benzodiazepine classes of medicines, such as Selective Serotonin Reuptake Inhibitors (SSRIs) or Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), are often discussed as therapeutic options for anxiety and panic disorder, as they are not associated with the same risks of physical dependence.


Q: Is the liquid form of Clonazepam used for the same conditions as the tablet form?

The oral liquid form and the tablet forms are typically approved for the same conditions, as they contain the same active ingredient. The liquid is often prescribed to facilitate administration for patients who may have difficulty swallowing tablets.


Q: Are there specific risks associated with Clonazepam in children and adolescents?

Clonazepam is specifically not approved for the treatment of panic disorder in pediatric patients but is approved for certain seizure disorders. Official safety information notes that side effects, such as mood changes, have been observed with greater frequency in children compared to other groups.


Q: Does Clonazepam interact with common over-the-counter cold and flu medications?

Official documents note a risk because certain over-the-counter cold and flu medications may contain ingredients (such as antihistamines or cough suppressants) that increase the chance of side effects like dizziness, drowsiness, or difficulty concentrating.


Q: Can Clonazepam cause vivid dreams or sleep disturbances?

The medicine's effect on the central nervous system may cause sleep disturbances. Official lists of adverse reactions include reports of difficulty with sleeping (insomnia) and, in rare instances, vivid dreams.


Q: What should a person do if they suspect an allergic reaction to Clonazepam?

Official health guidelines describe the necessity of seeking immediate emergency medical attention if symptoms of a severe allergic reaction occur, which include sudden swelling of the lips, mouth, or throat, difficulty breathing, or severe confusion.

How should Clonazepam be stored and disposed of?

Storage Requirements

Clonazepam tablets must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F), with permitted excursions up to 30 C (86 F). The product must be stored in a tightly closed, light-resistant container to protect it from moisture and light, as specified in regulatory labeling. It is a mandatory requirement to store the medication out of the reach and sight of children at all times.

Disposal Instructions

Unused or expired clonazepam should be disposed of via an official drug take-back program when available. If a take-back program is not accessible, the medication is recommended by the FDA to be mixed with an undesirable substance, placed in a sealed bag, and discarded in the household trash. It must not be flushed down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clonazepam found in:

A-Z Index: